Kasr Alainy hospital
Cairo, Egypt
NCT Number: NCT05294718
A prospective, randomized comparative study where investigators present results of off pump bidirectional Glenn operation done using either a venoatrial shunt or external shunt to decompress superior vena cava during clamping.
Looking for future studies?
Notify Me6 month–5 year
All sexes
Interventional
Not applicable
Cairo, Egypt
The bidirectional Glenn shunt (BDG) is performed for cyanotic congenital heart defects, with single-ventricle pathology . The BDG is usually performed with cardiopulmonary bypass (CPB) with its associated complications. The conduct of this operation without CPB can be associated with elevation of superior vena caval (SVC) pressure that may lead to neurological damage.
However, the safety of performing BDG without CPB reported by many authors but with some decompression techniques of the SVC at the time of clamping
Objective: investigators present results of off pump bidirectional Glenn operation done using either a venoatrial shunt or external shunt to decompress superior vena cava during clamping.
Design A prospective, randomized comparative study Setting: Single tertiary care cardiac center Participants 30 patients with functional single ventricle who will go off pump bidirectional Glenn.
Interventions: The patients will be randomly assigned into two groups: Group I (n = 15), where it will be done with a veno-atrial shunt(internal), and Group II (n = 15), where it will be done with an external shunt. All patients will go a complete neurological examination both preoperatively as well as postoperatively Intraoperative data will be collected and analyzed at the following time points: pre-clamping (post induction), during clamping and after de-clamping of SVC. variables such as arterial oxygen saturation (SaO2), systolic blood pressure (SBP), mean arterial blood pressure (MAP), diastolic blood pressure (DBP), and hematocrit, CVP, SVC pressure, cerebral perfusion pressure (CPP= MAP-CVP), PaO2, PaCO2 and ScvO2 will be analyzed.
Postoperatively, the patients will be stabilized in the intensive care unit (ICU) and after monitoring the SVC pressure for 12 h, the internal jugular vein cannula will be removed to prevent any jugular vein thrombosis. The patients will start aspirin (5 mg/kg/day), which will be continued indefinitely.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
glenn with internal shunt (veno-atrial shunt) where the surgeon established a shunt between distal SVC and the right atrium, Establishing a veno-atrial shunt.
Other names: Venoatrial shunt
Glenn with external shunt where the anesthesiologist connected the internal Jagular venous cannula which represent the SVC with the main lumen of the femoral cannula which represent the IVC through long venous extension
Other names: Jagulo femoral shunt
Time frame: during SVC clamping procedure
Measurment of superior vena cava pressure during off pumb Glenn
Time frame: "baseline, pre-intervention" "during the intervention procedure" "immediately after the intervention
Measurment of mean arterial blood preassure during off bumb Glenn
Time frame: "baseline, pre-intervention" "during the intervention procedure" "immediately after the intervention
CPP= MABP - CVP
Time frame: during SVC clamping procedure
Duration of SVC during off pump glenn with either Internal or external shunt
Kasr El Aini Hospital
Other
External Shunt Versus Internal Shunt for Off Pump Glenn (Original Article)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05053932
Anemia, Anemia, Hemolytic
Paris, IDF, France
View Trial DetailsNCT04046484
Acute Stroke, Brain Diseases
Gurgaon, India
View Trial DetailsNCT04437862
Acute Stroke, Brain Diseases
Tampa, Florida, United States
View Trial DetailsNCT02541591
Brain Diseases, Brain Ischemia
Genk, Belgium
View Trial Details